ClinicalTrials.Veeva

Menu

CGH-array in Prenatal Diagnosis of Isolated Severe and Early Intra-uterine Growth Restriction

C

Central Hospital, Nancy, France

Status

Unknown

Conditions

IUGR
Genetic Disease
Prenatal Disorder

Treatments

Genetic: CGH array analysis

Study type

Observational

Funder types

Other

Identifiers

NCT04729361
2021PI007

Details and patient eligibility

About

According to french recommandations for IUGR management we have to propose a CGH-array analysis if the IUGR is severe (bellow the 3rd percentile) and early (in the second trimester). However there is no data to support this point of view.

Enrollment

150 estimated patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant women
  • fetus with an isolated intra-uterine growth restriction (IUGR) severe (bellow the third percentile on CFEF curves) and early (between 21 and 24 gestational weeks).

Exclusion criteria

  • associated IUGR (with other abnormalities during prenatal screening)

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems